Lastly, this edition deserves special attention due to its emphasis on LP related to pathogens
and/or arising in the context of acquired immune suppression. Following, we will briefly …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia for
which we developed a nationwide network to collect data from new cases diagnosed in …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …

Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) are
reported in up to 20% patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which
usually affects elderly males and presents in the skin with frequent involvement of the bone …

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical
implications - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Blastic plasmacytoid dendritic cell neoplasm is a rare clinicopathologic entity, characterized
by strong skin tropism and a poor prognosis. The diagnosis is generally made by skin biopsy …